electroCore to Present at H.C. Wainwright BIOCONNECT Virtual Conference
04 Janeiro 2022 - 10:00AM
electroCore, Inc. (the “Company”), (NASDAQ: ECOR), a
commercial-stage bioelectronic medicine company, today announced
that its management team will give a presentation at the H.C.
Wainwright BIOCONNECT Virtual Conference. The conference is taking
place virtually from January 10 - 13, 2022. Details for access to
the presentation are as follows:
H.C. Wainwright BIOCONNECT Virtual
Conference:Date: January 10, 2022Time: 7:00 am ETInvestors
can register for the conference HERE.
Following the conference, a webcast replay of the presentation
will be available on the Investor section of the company’s website,
electroCore.
About electroCore, Inc.electroCore, Inc. is a
commercial stage bioelectronic medicine company dedicated to
improving patient outcomes through its non-invasive vagus nerve
stimulation therapy platform, initially focused on the treatment of
multiple conditions in neurology. The company's current indications
are the preventive treatment of cluster headache and migraine, the
acute treatment of migraine and episodic cluster headache, the
acute and preventive treatment of migraines in adolescents, and
paroxysmal hemicrania and hemicrania continua in adults.
For more information, visit www.electrocore.com.
Investors:
Rich Cockrell
CG Capital
404-736-3838
ecor@cg.capital
or
Media Contact:
Jackie Dorsky
electroCore
908-313-6331
Jackie.dorsky@electrocore.com
electroCore (NASDAQ:ECOR)
Gráfico Histórico do Ativo
De Mar 2024 até Abr 2024
electroCore (NASDAQ:ECOR)
Gráfico Histórico do Ativo
De Abr 2023 até Abr 2024